Document:

EX-10.1

 EXHIBIT 10.1 
 EATON CORPORATION 2012 STOCK PLAN 
 1. Purpose 

The Plan enables non-employee directors and professional and management employees who contribute significantly to the success of Eaton Corporation (the
“Company”) to participate in its future prosperity and growth and to identify their interests with those of the shareholders. The purpose of the Plan is to provide long term incentive through outstanding service to the Company and its
shareholders and to assist in recruiting and retaining people of outstanding ability and initiative in non-employee director, professional and management positions. The Plan supersedes the Company’s 2009 Stock Plan (the “Prior Plan”)
with respect to future awards. 
 2. Administration 
 (A) Employee Awards 
 With respect to employee awards, the Plan shall be administered
by the Compensation and Organization Committee of the Board of Directors (the “Committee”). 
 (B) Non-Employee Director
Awards 
 With respect to non-employee director awards, the Plan shall be administered by the Governance Committee of the Board of Directors.

 (C) Authority of Committees 
 With respect only to those awards for which it has administrative responsibility, the Committee and the Governance Committee shall each have complete authority (except as otherwise provided herein) to
interpret all provisions of the Plan and any award consistent with law, to determine the type and terms of awards consistent with the provisions of the Plan, to prescribe the form of instruments evidencing awards, to adopt, amend and rescind general
and special rules and regulations for its administration, and to make all other determinations necessary or advisable for its administration of the Plan. The determinations of the each committee shall be final and conclusive. Each committee may act
by resolution or in any other manner permitted by law. 
 The Committee may delegate its authority to one or more officers of the Company (a
“Delegate”) with respect to the granting of awards to employees who are not officers or directors of the Company who are subject to Section 16(b) of the Securities Exchange Act of 1934, as amended (Section “16b”).

 3. Shares Available 
 The
aggregate of (a) the number of Eaton common shares (“shares”) delivered by the Company in payment and upon exercise of awards to employees and non-employee directors and (b) the number of shares subject to outstanding awards to
employees and non-employee directors shall not exceed 21 million at any one time, plus any shares that were subject to outstanding awards under the Prior Plan as of the Effective Date that are subsequently canceled, expired, forfeited or
otherwise not issued under a Prior Plan award or settled in cash, subject to adjustments as authorized herein. The shares available for awards under the Plan will be reduced by (i) one share for each share subject to an award of options or
stock appreciation rights and (ii) 2.36 

 
shares for each share subject to an award of restricted shares, restricted share units, performance shares, performance share units or other sharebased awards denominated in shares. To the extent
that any award under the Plan or Prior Plan is forfeited, or any option or stock appreciation right terminates, expires or lapses without being exercised, the shares subject to such awards not delivered as a result thereof shall again be available
for awards under the Plan. Shares tendered or withheld to pay the exercise price of a stock option or to pay tax withholding of a stock option or stock appreciation right will count against the foregoing limitations and will not be added back to the
shares available under the Plan. When a stock appreciation right that may be settled for shares is exercised, the number of shares subject to the grant agreement shall be counted against the number of shares available for issuance under the Plan as
one (1) share for every share subject thereto, regardless of the number of shares used to settle the stock appreciation right upon exercise. Any shares that again become available for grant pursuant to this paragraph (including shares that were
subject to Prior Plan awards) shall be added back as one (1) share if such shares were subject to stock options or stock appreciation rights granted under the Plan or the Prior Plan, and as 2.36 shares if such shares were subject to awards of
restricted shares, restricted share units, performance shares, performance share units or other share-based awards denominated in shares granted under the Plan or the Prior Plan. Shares available for awards may consist, in whole or in part, of
authorized and unissued shares or treasury shares. 
 The maximum aggregate number of shares or share units underlying options or related to
other awards that may be granted to any employee during any three consecutive calendar year period is 1,200,000. In addition, no more than 5% of the total number of shares authorized for delivery under the Plan may be granted as performance shares,
restricted shares, stock appreciation rights or other share-based awards (other than stock options) which vest within less than one year after the date of grant. With respect to such awards in excess of 5% of the total number of such authorized
number of shares, the vesting period must exceed one year, with no more than one third of shares becoming vested at the end of each of the twelve-month periods following the date of grant; provided, however, the limitations set forth in this
sentence shall not apply (i) to awards of stock options and stock appreciation rights, (ii) to awards granted to non-employee directors, (iii) in the event of a change in control of the Company or divestment of a business, or
(iv) an employee’s death, disability or retirement. 
 Awards may be made under the Plan at any time after approval of the Plan by
shareholders at the 2012 annual meeting until the termination of the Plan in accordance with the terms hereof. Awards under the Plan shall be evidenced by a written agreement, contract, or other instrument or document, including an electronic
communication, as may from time to time be designated by the Company (an “Award Agreement”). 
 4. Eligibility for Awards

 Any salaried employee (including officers) of the Company or any of its subsidiaries occupying a professional or management position may
be granted an award. The Committee (or a Delegate) (a) will designate employees to whom grants are to be made, (b) will specify the number of options, stock appreciation rights, performance shares, performance share units, restricted
shares, restricted share units or other share-based awards subject to each grant, and (c) subject to Section 5(C), will specify the price of the award, if applicable. Non-employee directors are eligible to receive restricted shares as
provided under Section 6. 
 5. Stock Options 
 (A) Grants. 
 The Committee may grant to eligible employees (i) options which are
intended to qualify as incentive stock options (“Incentive Stock Options”) under the Internal Revenue Code, or (ii) options which are not intended to qualify as Incentive Stock Options. Each option will give the employee the right to
purchase a designated number of shares. The aggregate fair market value (at the time of grant) of shares for Incentive Stock Options under all plans of the Company which become initially exercisable by an employee during any calendar year shall not
exceed $100,000 (or such other amount as may be provided by the Internal Revenue Code or the regulations thereunder). 

 (B) Exercise. 
 Each option shall be exercisable on such date or dates, during such period and for such number of shares, as shall be determined by the Committee on the date of grant and set forth in the applicable Award
Agreement; provided, however, grants to employees subject to 16b shall not be exercisable for at least six months after those options are granted. Option awards that become exercisable based on continued employment with the Company shall become
exercisable over a minimum period of three years from the date of the grant, with the award vesting in its entirety at the end of such three-year period or ratably over such period. The Committee may, in its sole discretion, accelerate or extend
(but not beyond the ten-year term of the option) the times when an option may be exercised and the Management Compensation Committee (comprised of Company officers) may do likewise for employees who are not subject to Section 16b of the
Exchange Act. 
 (C) Price. 
 Each Award Agreement for stock options shall state the number of shares to which it pertains and the option price. The option price shall be the fair market value of the shares subject to the option on
the date of grant. The fair market value of a share shall be the closing price of a share as quoted on the New York Stock Exchange, unless the Committee specifies the use of a different method to determine the fair market value. In no event may any
option granted under the Plan be amended, other than pursuant to Section 11, to decrease the exercise price thereof, be cancelled in conjunction with a cash payment or the grant of any new award or any new option with a lower exercise price, or
otherwise be subject to any action that would be treated, for accounting purposes, as a “repricing” of such option, unless such amendment, cancellation or action is approved by the Company’s shareholders 

(D) Payment. 
 The Committee shall
establish in the applicable Award Agreement the time or times when an option may be exercised in whole or in part, and the method or methods by which, and the form or forms, including, without limitation, cash, shares or other awards, or any
combination thereof, having a fair market value on the exercise date equal to the exercise price in which payment of the exercise price may be made. The Committee shall determine acceptable methods of tendering shares or other consideration.

 (E) Performance Objectives. 
 The Committee may establish performance objectives for determining the exercisability of options as it deems appropriate, which may be measured on a corporate, subsidiary, business unit or individual
basis or a combination thereof. If performance objectives are established, the performance period will be a minimum of one year and may overlap other performance periods. 
 6. Non-employee Director Restricted Shares 
 Subject to approval of the Plan by shareholders
at the 2012 annual meeting, each person who on the grant date (as defined below in this Section 6) is serving as a non-employee director automatically shall be granted a number of restricted shares equal to the quotient resulting from dividing
(i) the annual retainer in effect on the grant date, by (ii) the closing price of a share on the New York Stock Exchange on the Monday immediately prior to the grant date or if that date is not a trading day on the New York Stock Exchange,
the trading day immediately preceding that 

 
Monday. The grant date is the fourth Wednesday of each January, beginning with January of 2013. Notwithstanding anything to the contrary herein, no non-employee director shall receive any award
under the Plan for a particular year if that director receives such a grant under any other stock plan of the Company. Restricted shares are actual shares issued to the non-employee directors which are subject to the terms and conditions set forth
in the Award Agreement as approved by the Governance Committee. 
 7. Employee Restricted Shares, Restricted Share Units and Other
Share-based Awards 
 (A) Share-Based Awards. 
 The Committee may grant other share-based awards to any eligible employee for no cash consideration, if permitted by applicable law, or for such consideration as may be determined by the Committee and
specified in the grant. Such grants may include restricted shares or restricted share units. The Committee may specify such criteria or periods for payment as it shall determine and the extent to which such criteria or periods have been met shall be
conclusively determined by the Committee and set forth in the Award Agreement. Other share-based grants may be paid in shares or other consideration related to shares, as specified by the grant, and shall have such terms and conditions as shall be
determined by the Committee and set forth in the Award Agreement. Sharebased awards shall vest over a minimum period of three years from the date of the grant, with the award vesting in its entirety at the end of such three-year period or ratably
over such period; provided, however, the limitations set forth in this sentence shall not apply in the event of a change in control of the Company, divestment of a business or an employee’s death, disability or retirement. 

(B) Performance Objectives. 
 The
Committee may establish performance objectives for determining the vesting of share-based awards as it deems appropriate, which may be measured on a corporate, subsidiary, business unit or individual basis or a combination thereof. If performance
objectives are established, the performance period will be a minimum of one year and may overlap other performance periods. 
 8. Performance
Awards 
 (A) Grants. 

The Committee may grant performance shares or performance share units to any eligible employee for no cash consideration, if permitted by applicable law,
or for such consideration as may be determined by the Committee and specified in the grant. The Committee shall establish award periods and shall establish in writing within the first 90 days of each award period the number of performance shares or
units to be earned and the Company performance objectives (as defined below) to be met. A performance share unit is equal in value to one share and subject to vesting on the basis of the achievement of specified performance objectives. Upon vesting,
performance share units will be settled by delivery of shares to the holder of the units equal to the number of vested performance share units, less a sufficient number of shares to satisfy tax withholding requirements. 

No grantee may receive a long-term incentive award in any performance period of more than 400,000 share equivalent units, subject to adjustment pursuant
to Section 11. 
 The Award Agreement shall specify if the grantee shall be entitled to receive current or deferred payments of cash in
respect of vested performance units corresponding to the dividends payable on shares. 

 (B) Performance Objectives. 
 (1) The performance objectives for performance share or performance share unit grants shall be set forth in the related Award Agreement and shall consist of objective tests based on one or more of the
following: the Company’s earnings, cash flow, cash flow return on gross capital, revenues, financial return ratios, market performance, shareholder return and/or value, operating profits, net profits, earnings per share, operating earnings per
share, profit returns and margins, share price, working capital, and changes between years or periods, or returns over years or periods that are determined with respect to any of the above-listed performance criteria. 

(2) The performance period may extend over one to five calendar years, and may overlap one another, although no two performance periods may consist
solely of the same calendar years. Performance Objectives may be measured solely on a corporate, subsidiary or business unit basis, or a combination thereof. Further, Performance Objectives may reflect absolute entity performance or a relative
comparison of entity performance to the performance of a peer group of entities or other external measure of the selected Performance Objectives. 
 (3) When the Performance Objectives for an award period are established, the formula for any such award may include or exclude items to measure specific objectives, such as losses from discontinued
operations, extraordinary gains or losses, the cumulative effect of accounting changes, acquisitions or divestitures, foreign exchange impacts and any unusual, nonrecurring gain or loss, and will be based on accounting rules and related Company
accounting policies and practices in effect on the date of the award. 
 (4) After performance shares or units have been granted and performance
objectives have been established, the initial performance share or unit target award may be increased or decreased based only upon the performance level achieved within a performance period. 
 9. Other Awards 
 In limited circumstances where the Committee determines that the use of
stock options or restricted shares or restricted share units is inadvisable for tax or other regulatory reasons, it may grant stock appreciation rights or other types of awards to eligible employees. Stock appreciation rights entitle the holder,
upon exercise, to receive a number of shares or cash, as the Committee may determine, equal to the increase in fair market value of a number of shares designated by such rights from the date of grant to the date of exercise. The number of shares
subject to a stock appreciation right shall be counted against the individual limit on the maximum number of shares that may be awarded to any employee during any three consecutive calendar year periods, and against the maximum number of shares
which may be delivered under the Plan. The exercise price per share of a stock appreciation right shall not be less than the fair market value of a share on the grant date and the term of a stock appreciation right may be no longer than ten years.
The fair market value of a share shall be the closing price of a share as quoted on the New York Stock Exchange, unless the Committee specifies the use of a different method to determine fair market value. In no event may any stock appreciation
right granted under the Plan be amended, other than pursuant to Section 10, to decrease the exercise price thereof, be cancelled in conjunction with a cash payment or the grant of any new award or any new stock appreciation right with a lower
exercise price, or otherwise be subject to any action that would be treated, for accounting purposes, as a “repricing” of such stock appreciation right, unless such amendment, cancellation or action is approved by the Company’s
shareholders. Stock appreciation rights and other types of awards covered in this Section 9 that become exercisable based on continued employment shall vest over a minimum period of three years from the date of the grant, with the award vesting
in its entirety at the end of such three-year period or ratably over such period. 
 10. Transfers 

Except as otherwise provided by the Committee, awards under the Plan are not transferable other than by will or the laws of descent and distribution. A
transferred award may be exercised by the transferee only to the extent that the grantee would have been entitled to exercise the award had the award not been transferred. 

 Notwithstanding anything herein to the contrary, the transfer of Incentive Stock Options shall be limited as
required by the Internal Revenue Code and applicable regulations. 
 11. Adjustments 

In the event of a reorganization, merger, consolidation, reclassification, recapitalization, combination or exchange of shares, stock split, stock
dividend, rights offering or similar event affecting shares of the Company, the following shall be equitably adjusted: (a) the number and class of shares (i) reserved under the Plan, (ii) for which awards may be granted to an
individual, and (iii) covered by outstanding awards denominated in shares or share units; (b) the prices relating to outstanding awards; and (c) the appropriate fair market value and other price determinations for such awards.

 12. Qualified Performance-Based Awards 
 (A) The provisions of the Plan are intended to ensure that all options, performance shares and performance share units granted hereunder to any individual who is or may be a “covered employee”
(within the meaning of Section 162(m)(3) of the Internal Revenue Code) qualify for the Section 162(m) exception (the “Section 162(m) Exception”) for performance-based compensation (a “Qualified Performance-Based
Award”), and all of the awards specified in this Section 12(A) and the Plan shall be interpreted and operated consistent with that intention. 
 (B) Each Qualified Performance-Based Award (other than an option or stock appreciation right) shall be earned, vested and payable (as applicable) only upon the achievement of one or more Performance
Objectives, together with the satisfaction of any other conditions, such as continued employment, as the Committee may determine to be appropriate. Qualified Performance-Based Awards may not be amended, nor may the Committee exercise discretionary
authority in any manner that would cause the Qualified Performance-Based Award to cease to qualify for the Section 162(m) Exception. Awards shall be contingent on continued employment by the Company during each performance period; provided,
however, that this requirement will not apply in the event of termination of employment by reason of death or disability (as determined by the Committee). In the event of termination of employment of a participant for these reasons during any
incomplete performance periods, awards for such performance periods shall be prorated for the amount of service by the participant during the performance period. The prorated awards shall be payable to the participant (or to his or her estate) at
the same time as awards for such performance periods are paid to the other participants and shall be subject to the same requirements for attainment of the specified Performance Objectives as apply to such other participants’ awards.

 (C) The Committee shall certify in writing as to the measurement of performance by the Company and the business units relative to Performance
Objectives and the resulting earned performance awards. The Committee shall rely on such financial information and other materials as it deems necessary and appropriate to enable it to certify to the percentage of achievement of Performance
Objectives. The Committee shall make its determination not later than March 15 following the end of the performance measurement period. 

13. General Provisions 
 (A) Awards
granted under the Plan are subject to the Company’s policy, adopted by the Board of Directors, that provides that, if the Board determines that an executive engaged in any fraud, misconduct or other bad-faith action that, directly or
indirectly, caused or partially caused the need for a material accounting restatement for any period as to which a performance-based award was paid or credited to the executive, the performance based award is subject to reduction, cancellation or
reimbursement at the discretion of the Board. 

 (B) With respect to awards granted pursuant to Sections 5, 7 and 9 above, the Committee is prohibited from
waiving any vesting or restriction periods applicable to awards except in the case of death, disability, retirement, change in control or divestment of a business. 
 (C) The Company shall have the right to deduct from any cash payment made under the Plan any taxes required by law to be withheld. It shall be a condition to the obligation of the Company to deliver
shares that the participant pay the Company such amount as it may request for the purpose of satisfying any such tax liability. Any award under the Plan may provide that the participant may elect, in accordance with any Committee regulations, to pay
the amount of such withholding taxes in shares. 
 (D) No person, estate or other entity shall have any of the rights of a shareholder with
reference to shares subject to an award until a certificate or certificates for the shares have been delivered to that person, estate or other entity. The Plan shall not confer upon any non-employee director or employee any right to continue in that
capacity. 
 (E) The Plan and all determinations made and actions taken pursuant hereto, to the extent not governed by the laws of the United
States, shall be governed by the laws of Ohio. 
 14. Amendment and Termination 
 The Board of Directors of the Company may alter, amend or terminate the Plan from time to time, except that the Plan may not be materially amended without shareholder approval if shareholder approval is
required by law, regulation or an applicable stock exchange rule. Notwithstanding the previous sentence, the Plan may not be amended without shareholder approval to (i) increase the 
 aggregate number of shares which may be issued under the Plan, (ii) increase the maximum number of shares which may be granted to any employee, or (iii) grant options or stock appreciation
rights at a purchase price below fair market value on the date of grant. 
 15. Effective and Termination Dates 

The Plan will become effective if and when approved by shareholders at the 2012 annual meeting of shareholders (the date of such approval the
“Effective Date”). No new awards shall be granted to any employee or non-employee Director under any other previously approved Company stock plan after the Plan becomes effective. 
 No awards shall be granted under the Plan after the date that is ten years after the Effective Date. Awards granted before that date shall remain valid thereafter in accordance with their terms.Form of Eleventh Supplemental Indenture

 Exhibit 4.12 
  

 
 QWEST CORPORATION 

7.00% Notes due 2052 
  

 
 Eleventh
Supplemental Indenture 
 Dated as of June 25, 2012 

 
  

U.S. BANK NATIONAL ASSOCIATION, 
 as Trustee 

 ELEVENTH SUPPLEMENTAL INDENTURE dated as of June 25, 2012 (this “Supplemental
Indenture”) by and between QWEST CORPORATION, a Colorado corporation (formerly named U S WEST Communications, Inc.) (the “Company”), and U.S. BANK NATIONAL ASSOCIATION, as trustee under the Indenture (as defined below) with respect to
the Notes (as defined below) (the “Trustee”), as amended and supplemented by the First Supplemental Indenture (as defined below), the Second Supplemental Indenture (as defined below), the Third Supplemental Indenture (as defined below),
the Fourth Supplemental Indenture (as defined below), the Fifth Supplemental Indenture (as defined below), the Sixth Supplemental Indenture (as defined below), the Seventh Supplemental Indenture (as defined below), the Eighth Supplemental Indenture
(as defined below), the Ninth Supplemental Indenture (as defined below) and the Tenth Supplemental Indenture (as defined below). The Trustee, and each other trustee appointed as such with respect to the Securities (as defined below) of any series
issued under the Indenture, shall be the “Trustee” (as defined in the Indenture, as supplemented hereby) for all purposes under the Indenture with respect to the applicable series of Securities but, for the avoidance of doubt, not with
respect to any series of Securities for which such Trustee has not been appointed trustee under the terms of the Indenture or any supplement thereto. 
 RECITALS 
 WHEREAS, the Company and Bank of New York Trust Company,
National Association (as successor in interest to Bank One Trust Company, N.A. and J.P. Morgan Trust Company, National Association), are parties to that certain Indenture dated as of October 15, 1999 (the “Base Indenture”, and as
amended and supplemented by the First Supplemental Indenture, the Second Supplemental Indenture, the Third Supplemental Indenture, the Fourth Supplemental Indenture, the Fifth Supplemental Indenture, the Sixth Supplemental Indenture, the Seventh
Supplemental Indenture, the Eighth Supplemental Indenture, the Ninth Supplemental Indenture, the Tenth Supplemental Indenture and this Eleventh Supplemental Indenture, the “Indenture”) providing for the issuance from time to time of senior
debt securities (“Securities”) to be issued in one or more series. 
 WHEREAS, the Company and the Trustee are parties
to the First Supplemental Indenture (the “First Supplemental Indenture”) dated as of August 19, 2004, providing for the amendment and supplement of the terms of the Base Indenture and the issuance by the Company of a series of
Securities designated as its 7.875% Notes due 2011, in an aggregate principal amount of $575,000,000, none of which are currently outstanding. 
 WHEREAS, the Company and the Trustee are parties to the Second Supplemental Indenture (the “Second Supplemental Indenture”) dated as of November 23, 2004, providing for the issuance by the
Company of additional notes of its series of Securities designated as its 7.875% Notes due 2011, in an aggregate principal amount of $250,000,000, none of which are currently outstanding. 

WHEREAS, the Company and the Trustee are parties to the Third Supplemental Indenture (the “Third Supplemental Indenture”) dated
as of June 17, 2005, providing for the issuance by the Company of a series of Securities designated as its 7.625% Notes due 2015, in an aggregate principal amount of $400,000,000, $91,885,000 of which are currently outstanding, and a series of
Securities designated as its Floating Rate Notes due 2013, in an aggregate principal amount of $750,000,000, all of which are currently outstanding. 

 WHEREAS, the Company and the Trustee are parties to the Fourth Supplemental Indenture (the
“Fourth Supplemental Indenture”) dated as of August 8, 2006, providing for the issuance by the Company of a series of Securities designated as its 7.5% Notes due 2014, in an aggregate principal amount of $600,000,000, all of which are
currently outstanding. 
 WHEREAS, the Company and the Trustee are parties to the Fifth Supplemental Indenture (the “Fifth
Supplemental Indenture”) dated as of May 16, 2007, providing for the issuance by the Company of a series of Securities designated as its 6.5% Notes due 2017, in an aggregate principal amount of $500,000,000, all of which are currently
outstanding. 
 WHEREAS, the Company and the Trustee are parties to the Sixth Supplemental Indenture (the
“Sixth Supplemental Indenture”) dated as of April 13, 2009, providing for the issuance by the Company of a series of Securities designated as its
8 3/8% Notes due 2016, in an aggregate principal
amount of $810,500,000, $235,007,000 of which are currently outstanding. 
 WHEREAS, the Company and the Trustee are
parties to the Seventh Supplemental Indenture (the “Seventh Supplemental Indenture”) dated as of June 8, 2011, providing for the issuance by the Company of a series of Securities designated as its 7.375% Notes due 2051, in an
aggregate principal amount of $661,250,000, all of which are currently outstanding. 
 WHEREAS, the Company and the Trustee are
parties to the Eighth Supplemental Indenture (the “Eighth Supplemental Indenture”) dated as of September 21, 2011, providing for the issuance by the Company of a series of Securities designated as its 7.50% Notes due 2051, in an
aggregate principal amount of $575,000,000, all of which are currently outstanding. 
 WHEREAS, the Company and the Trustee are
parties to the Ninth Supplemental Indenture (the “Ninth Supplemental Indenture”) dated as of October 4, 2011, providing for the issuance by the Company of a series of Securities designated as its 6.75% Notes due 2021, in an aggregate
principal amount of $950,000,000, all of which are currently outstanding. 
 WHEREAS, the Company and the Trustee are parties to
the Tenth Supplemental Indenture (the “Tenth Supplemental Indenture”) dated as of April 2, 2012, providing for the issuance by the Company of a series of Securities designated as its 7.00% Notes due 2052, in an aggregate principal
amount of $525,000,000, all of which are currently outstanding. 
 WHEREAS, the Company desires and has requested the Trustee to
execute and deliver this Supplemental Indenture in order to establish and provide for the issuance by the Company of a series of Securities designated as its 7.00% Notes due 2052 (the “Notes”). 

WHEREAS, Section 9.01(8) of the Base Indenture provides that a supplemental indenture may be entered into by the Company and the
Trustee without the consent of any Holders to establish the form and terms and conditions of Securities of any Series as permitted by Section 2.02 of the Base Indenture. 

  
 2 

 WHEREAS, the conditions set forth in the Indenture for the execution and delivery of this
Supplemental Indenture have been complied with. 
 WHEREAS, all things necessary to make this Supplemental Indenture a valid
agreement of the Company and the Trustee, in accordance with its terms, and a valid supplement to the Indenture have been done. 

NOW, THEREFORE, in consideration of the premises and the purchase and acceptance of the Notes by the Holders thereof, the Company
covenants and agrees with the Trustee, for the equal and ratable benefit of the Holders of the Notes, that the Indenture is hereby supplemented, to the extent expressed herein, as follows: 

ARTICLE 1 

THE NOTES 
 Section 1.01
Designation of Notes. 
 The changes, modifications and supplements to the Indenture effected by this Supplemental
Indenture shall be applicable only with respect to, and govern the terms of, the Notes, which shall not be limited in aggregate principal amount, and shall not apply to any other Securities that have been or may be issued under the Indenture unless
a supplemental indenture with respect to such other Securities specifically incorporates such changes, modifications and supplements. Pursuant to this Supplemental Indenture, there is hereby created and designated a series of Securities under the
Indenture entitled “7.00% Notes due 2052” in an initial aggregate principal amount of $400,000,000. The Notes shall be in substantially the form of Exhibit A hereto. Subject to the terms in the Indenture, as supplemented by this
Supplemental Indenture, the Company may, at its option, without the consent of the Holders of the Notes, issue additional notes from time to time that will constitute a single series of Securities under the Indenture together with the previously
outstanding Notes. 
 Section 1.02 Other Terms of the Notes. 
 Without limiting the foregoing provisions of this Article 1, the terms of the Notes shall be as set forth in the form of Note set forth in Exhibit A hereto and as provided in the Indenture. The
Notes shall be issuable in denominations of $25 and integral multiples of $25 in excess thereof. 
 Section 1.03 Agents.

 (a) The Notes shall be payable and may be presented for payment, purchase, registration of transfer and exchange, without
service charge, at the office of the Company maintained for such purpose in New York, New York, which shall initially be the office or agency of the Trustee. 

  
 3 

 (b) The Trustee shall also serve as security registrar for the purpose of registering Notes
and transfers or exchanges of Notes. 
 (c) The Company may from time to time designate one or more additional offices or
agencies where Notes may be presented or surrendered for payment or may be surrendered for registration of transfer or exchange in accordance with the Base Indenture. 
 Section 1.04 Definitions. 
 (a) Capitalized terms used but not
otherwise defined herein shall have the meanings ascribed to such terms in the Indenture. To the extent terms defined herein differ from the Indenture, the terms defined herein will govern. 

(b) For all purposes of the Indenture, except as otherwise expressly provided or unless the context otherwise requires, the terms defined
in this Supplemental Indenture have the meanings assigned to them in this Supplemental Indenture, and include the plural, as well as the singular. 
 ARTICLE 2 
 ADDITIONAL TERMS 

Section 2.01 Form and Dating 
 (a) The Notes issued shall be represented by one or more global notes substantially in the form set forth in Exhibit A hereto, deposited with the Trustee, as custodian for The Depository Trust
Company, New York, New York, or a successor thereto registered under the Securities Exchange Act of 1934, as amended, or other applicable statute or regulation (the “Depository”), duly executed by the Company and authenticated by the
Trustee as hereinafter provided and shall bear any legends required by applicable law (the “Global Notes”). 
 (b) The
aggregate principal amount of each of the Global Notes may from time to time be increased or decreased by adjustments made by the Trustee on Schedule I to the Global Notes and on the records of the Trustee, as custodian for the Depository.

 Section 2.02 Book-Entry Provisions for Global Notes 
 (a) The Global Notes initially shall (i) be registered in the name of the Depository or the nominee of such Depository, (ii) be delivered to the Trustee as custodian for such Depository and
(iii) bear the legends required by the Depository as set forth in Exhibit A. 
 (b) Members of, or
participants in, the Depository (“Participants”) shall have no rights under this Indenture with respect to any Global Note held on their behalf by the Depository, or the Trustee as its custodian, or under any such Global Note, and the
Depository may be treated by the Company, the Trustee and any agent of the Company or the Trustee as the absolute owner of the Global Note for all purposes whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, the
Trustee or any agent of the Company or the Trustee from giving effect to any written certification, proxy or other authorization furnished by the Depository or impair, as between the Depository and Participants, the operation of customary practices
governing the exercise of the rights of a Holder of any Note. 

  
 4 

 (c) The Holder of any Global Note may grant proxies and otherwise authorize any Person,
including Participants and Persons that may hold interests through Participants, to take any action which a Holder of any Note is entitled to take under this Indenture or the Notes. 

(d) Notwithstanding any other provisions of the Indenture, a Global Note may only be transferred in whole, and not in part, and may not
be transferred as a whole except by the Depository to a nominee of the Depository or by a nominee of the Depository to the Depository or another nominee of the Depository or by the Depository or any such nominee to a successor Depository or a
nominee of such successor Depository. Definitive Notes shall be transferred to all beneficial owners in exchange for their beneficial interests in Global Notes if (i) the Depository notifies the Company that it is unwilling or unable to act as
Depository for any Global Note and a successor Depository is not appointed by the Company within 90 days, (ii) the Depository ceases to be a clearing agency registered or in good standing under the Securities Exchange Act of 1934, as amended,
or other applicable statute or regulation, and a successor Depository is not appointed by the Company within 90 days or (iii) if an Event of Default shall have occurred and be continuing, but only if, in the case of item (i) or
(ii) above, the Company provides written transfer directions to the Trustee or, in the case of item (iii) above, the holders of a majority of the aggregate principal amount of the Notes provide written transfer directions to the Trustee.
In addition, definitive Notes shall be transferred to all beneficial owners in exchange for their beneficial interests in Global Notes if the Company, in its sole discretion, determines not to require that all of the Notes be represented by a Global
Note. In connection with the transfer of a Global Note as an entirety pursuant to this Section 2.02(d), such Global Note shall be deemed to be surrendered to the Trustee for cancellation and (i) the Company shall execute and (ii) the
Trustee shall, upon written instructions from the Company, authenticate and deliver to each beneficial owner identified by the Depository in exchange for its beneficial interest in such Global Note, an equal aggregate principal amount of definitive
Notes of authorized denominations. 
 (e) The Trustee shall have no responsibility for the actions or omissions of the
Depository or the accuracy of the books and records of the Depository. 
 ARTICLE 3 

MISCELLANEOUS 

Section 3.01 Amendment and Supplement. 
 This Supplemental Indenture and the Notes may be amended or supplemented as provided for in the Indenture. 

  
 5 

 Section 3.02 Indenture. 
 As supplemented hereby, the Indenture is in all respects ratified and confirmed, and the Base Indenture and this Supplemental Indenture shall be read and construed as one and the same instrument. In the
event of any conflict between this Supplemental Indenture and the Indenture, the provisions of this Supplemental Indenture shall prevail. 

Section 3.03 Governing Law. 
 The laws of the State of New York shall govern this Supplemental Indenture and the Notes created hereby. 
 Section 3.04 No Adverse Interpretation of Other Agreements. 
 This
Supplemental Indenture may not be used to interpret another indenture, loan or debt agreement of the Company or a Subsidiary. Any such indenture, loan or debt agreement may not be used to interpret this Supplemental Indenture. 

Section 3.05 Successors and Assigns. 
 All covenants and agreements of the Company in this Supplemental Indenture and the Notes shall bind its successors and its assigns under the Base Indenture. All agreements of the Trustee in this
Supplemental Indenture shall bind its successors and its assigns under the Base Indenture. 
 Section 3.06 Duplicate Originals.

 This Supplemental Indenture may be executed in counterparts, each of which shall be an original, but such counterparts shall
together constitute but one instrument. 
 Section 3.07 Severability. 

In case any one or more of the provisions contained in this Supplemental Indenture or in the Notes shall for any reason be held to be
invalid, illegal or unenforceable in any respect, such invalidity, illegality or unenforceability shall not affect any other provisions of this Supplemental Indenture or of the Notes. 

[Signature Page Follows] 

  
 6 

 SIGNATURES 
 IN WITNESS WHEREOF, the parties have caused this Supplemental Indenture to be duly executed, all as of the date first above written. 

 

			
	QWEST CORPORATION
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	U.S. BANK NATIONAL ASSOCIATION
		
	By:	 	  

	Name:	 	
	Title:	 	

 Exhibit A 
 THIS NOTE IS A GLOBAL NOTE WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITORY OR A NOMINEE OF A DEPOSITORY OR A SUCCESSOR DEPOSITORY. THIS NOTE IS
NOT EXCHANGEABLE FOR NOTES REGISTERED IN THE NAME OF A PERSON OTHER THAN THE DEPOSITORY OR ITS NOMINEE EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE, AND NO TRANSFER OF THIS NOTE (OTHER THAN A TRANSFER OF THIS NOTE AS A WHOLE BY THE
DEPOSITORY TO A NOMINEE OF THE DEPOSITORY OR BY A NOMINEE OF THE DEPOSITORY TO THE DEPOSITORY OR ANOTHER NOMINEE OF THE DEPOSITORY) MAY BE REGISTERED EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE. 

UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY, A NEW YORK CORPORATION
(“DTC”), TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF
DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE
REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 

  
 A-1

			
	No.                     	  	PRINCIPAL AMOUNT
	 CUSIP No. 74913G501
	  	$        

 Qwest Corporation 7.00% Note due 2052 

QWEST CORPORATION, a corporation duly organized and existing under the laws of the State of Colorado (such corporation, and its
successors and assigns under the Indenture hereinafter referred to, being herein called the “Company”), for value received, hereby promises to pay to Cede & Co., or registered assigns, the principal sum of
             MILLION DOLLARS ($            ) (or such other amount as shall be listed on Schedule I attached hereto) on
July 1, 2052 (the “Maturity Date”), unless previously redeemed on any redemption date, by wire transfer of immediately available funds of such coin or currency of the United States of America as at the time of payment shall be legal
tender for the payment of public and private debts and to pay interest thereon quarterly on January 1, April 1, July 1 and October 1 of each year, commencing October 1, 2012 (each, an “Interest Payment
Date”), and on the Maturity Date at the rate per annum specified in the title of this Note, from June 25, 2012 (or from the most recent Interest Payment Date to which interest has been paid or duly provided for) until payment of such
principal sum has been made or duly provided for. Notwithstanding the foregoing, if the Company shall default in the payment of interest due on any Interest Payment Date, then this Note shall bear interest from the most recent Interest Payment Date
to which interest has been paid or duly provided for or, if no interest has been paid on this Note or duly provided for, from June 25, 2012. The interest so payable on any Interest Payment Date, as long as the Notes are represented by a global
security, subject to certain exceptions provided in the Indenture referred to herein, will be paid to the person in whose name this Note shall be registered at the close of business on the Business Day (as defined below) prior to such Interest
Payment Date. If any Interest Payment Date or the Maturity Date is a Legal Holiday (as defined in the Indenture referred to below) in New York, New York, the required payment shall be made on the next succeeding day that is not a Legal Holiday as if
it was made on the date such payment was due and no interest will accrue on the amount so payable for the period from and after such Interest Payment Date or Maturity Date, as the case may be, to such next succeeding day. Interest will be computed
on the basis of a 360-day year consisting of twelve 30-day months. The amount of interest payable for any period shorter than a full quarterly interest period will be computed on the basis of the number of days elapsed in a 90-day quarter of three
30-day months. “Business Day” means any day other than a Legal Holiday. 
 This Note is one of the duly authorized
series of Securities of the Company, designated as the Company’s “7.00% Notes due 2052” (the “Notes”), initially limited to the aggregate principal amount of $400,000,000, all issued or to be issued under and pursuant to an
Indenture dated as of October 15, 1999 between the Company and Bank of New York Trust Company National Association, as trustee (as successor in interest to Bank One Trust Company, N.A. and J.P. Morgan Trust Company, National Association), as
amended and supplemented by the First Supplemental Indenture dated as of August 19, 2004 between the Company and U.S. Bank National Association, as trustee (the “Trustee”), the Second Supplemental Indenture dated as of
November 23, 2004 between the Company and the Trustee, the Third Supplemental Indenture dated as of June 17, 2005 between the Company and the Trustee, the Fourth Supplemental 

  
 A-2

 
Indenture dated as of August 8, 2006 between the Company and the Trustee, the Fifth Supplemental Indenture dated as of May 16, 2007 between the Company and the Trustee, the Sixth
Supplemental Indenture dated as of April 13, 2009 between the Company and the Trustee, the Seventh Supplemental Indenture dated as of June 8, 2011 between the Company and the Trustee, the Eighth Supplemental Indenture dated as of
September 21, 2011 between the Company and the Trustee, the Ninth Supplemental Indenture dated as of October 4, 2011 between the Company and the Trustee, the Tenth Supplemental Indenture dated as of April 2, 2012 between the Company
and the Trustee and the Eleventh Supplemental Indenture dated as of June 25, 2012 between the Company and the Trustee, as such may be further amended, modified or supplemented from time to time (as so amended, modified or supplemented, the
“Indenture”), to which Indenture and all indentures supplemental thereto reference is hereby made for a description of the rights, limitation of rights, obligations, duties and immunities thereunder of the Trustee, the Company and the
Holders (the words “Holders” or “Holder” meaning the registered holders or registered holder of the Notes). 

The Notes shall be redeemable at the option of the Company, in whole or in part, at any time on and after July 1, 2017, at a
redemption price equal to 100% of the principal amount redeemed plus accrued and unpaid interest to, but not including, the redemption date. 
 If money sufficient to pay the redemption price of and accrued interest on all of the Notes (or portions thereof) to be redeemed on the redemption date is deposited with the Trustee or paying agent on or
before the redemption date and certain other conditions specified in the Indenture are satisfied, then on and after such redemption date, interest will cease to accrue on such Notes (or such portion thereof) called for redemption. 

Notice of any redemption will be mailed not less than 15 nor more than 60 calendar days before the redemption date to the Holder hereof
at its registered address. Unless the Company defaults in payment of the redemption price, on and after the redemption date interest will cease to accrue on the principal amount of this Note. Neither the Company nor the Trustee shall be required to
register the transfer of or exchange the Notes to be redeemed by the Company under the terms hereof. 
 In case an Event of
Default shall occur and be continuing, the principal hereof may be declared, and upon such declaration shall become, due and payable in the manner, with the effect and subject to the conditions provided in the Indenture. 

Subject to certain specified exceptions, the Indenture contains provisions permitting (i) the Company and the Trustee, with the
written consent of the Holders of a majority in principal amount of the outstanding Securities of each series affected by a supplemental indenture (with each series voting as a class), to enter into a supplemental indenture to add any provisions to
or to change or eliminate any provisions of the Indenture or of any supplemental indenture or to modify, in certain specified instances without the consent of Holders, the rights of the Holders of each such series, and (ii) the Holders of a
majority in principal amount of the outstanding Securities of each series affected by such waiver (with each series voting as a class), by notice to the Trustee to waive compliance by the Company with any provision of the Indenture, any supplemental
indenture or the Securities of any such series. 

  
 A-3

 No reference herein to the Indenture and no provision of this Note or of the Indenture shall
alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of, premium, if any, and interest on this Note at the place, at the respective times, at the rate, and in the coin or currency herein
prescribed. 
 No director, officer, employee or stockholder, as such, of the Company shall have any liability for any
obligations of the Company under this Note or the Indenture or for any claim based on, in respect of or by reason of such obligations or their creation. Each Holder, by accepting this Note, waives and releases all such liability. The waiver and
release are part of the consideration for the issue of this Note. 
 The laws of the State of New York shall govern the
Indenture and this Note. 
 Ownership of this Note shall be proved by the register for the Notes kept by the Registrar. The
Company, the Trustee and any agent of the Company may treat the person in whose name a Note is registered as the absolute owner thereof for all purposes. 
 The indebtedness evidenced by this Note is senior and unsecured and will rank in right of payment on parity with all other unsecured and unsubordinated obligations of the Company. 

Terms used herein without definition that are defined in the Indenture shall have the meanings assigned to them in the Indenture.

 Pursuant to a recommendation promulgated by the Committee on Uniform Security Identification Procedures, the Company has
caused CUSIP numbers to be printed on the Notes and the Trustee may use CUSIP numbers in notices of redemption as a convenience to Holders. No representation is made as to the accuracy of such numbers either as printed on the Notes or as contained
in any notice of redemption and reliance may be placed only on the other identification numbers placed thereon. 
 Unless the
Certificate of Authentication hereon has been executed by the Trustee under the Indenture referred to herein by the manual or facsimile signature of one of its authorized officers, or on behalf of the Trustee by the manual or facsimile signature of
an authorized officer of the Trustee’s authenticating agent, this Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. 

  
 A-4

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed, manually or
by facsimile, and its corporate seal or a facsimile of its corporate seal to be imprinted hereon. 
 Date:
[                    ] 
  

							
		 		 	QWEST CORPORATION
	 (SEAL)
	 		 		 	
		 		 	By:	 	  

		 		 	Name:	 	
		 		 	Title:	 	
				
		 		 	By:	 	  

		 		 	Name:	 	
		 		 	Title:	 	

  
 A-5

 CERTIFICATE OF AUTHENTICATION 

This is one of the Notes of the series designated herein, issued under the Indenture described herein. 

 

			
	U.S. BANK NATIONAL ASSOCIATION, as Trustee
		
	By:	 	  

		 	Authorized Signatory

  
 A-6

 ASSIGNMENT FORM 
 FOR VALUE RECEIVED, the undersigned hereby sell(s), assign(s) and transfer(s) unto 
  

			
	  
 	 	  

 Please insert social security number or other identifying number of assignee:

			
	  
 	 	  

 Please print or type name and address (including zip code) of assignee:

  

			
	  
	 	
	  
	 	
	  
	 	
	  
	 	

 the within Note and all rights thereunder, hereby irrevocably constituting and appointing
                             attorney to transfer said Note of Qwest Corporation on the books of Qwest
Corporation, with full power of substitution in the premises. 
  

					
	  
 	 	  
	 Dated:
	 	  
	 	

 NOTICE: The signature to this assignment must correspond with the name as written upon the face of this
Note in every particular without alteration or enlargement or any change whatsoever. 

  
 A-7

 SCHEDULE I 
 CHANGES TO PRINCIPAL AMOUNT OF SECURITIES EVIDENCED BY GLOBAL NOTE 
 The initial
principal amount of Securities evidenced by this Global Note is $        . 
  

							
	 Date
	  	 Principal Amount of

Securities by which
 this Global Note is to
 be Reduced or

Increased, and Reason
 for Reduction or
 Increase
	  	 Remaining Principal

Amount of Securities
Represented by this
 Global Note
	  	 Notation Made by

		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	
		  		  		  	

  
 A-8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00205-of-00352.parquet"}]]